DAPTOMYCIN

Generic: DAPTOMYCIN

Sagent PharmaceuticalsManufacturer
INTRAVENOUSRoute
DAPTOMYCINActive Substance
2019-11-15Original Approval

DAPTOMYCIN is FDA application ANDA207104, sponsored by SAGENT PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
768 reports
2
OFF LABEL USE
703 reports
3
ACUTE KIDNEY INJURY
628 reports
4
EOSINOPHILIC PNEUMONIA
489 reports
5
PYREXIA
481 reports
6
RHABDOMYOLYSIS
389 reports
7
EOSINOPHILIA
387 reports
8
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
344 reports
9
BLOOD CREATINE PHOSPHOKINASE INCREASED
329 reports
10
PRODUCT USE IN UNAPPROVED INDICATION
321 reports